News
CVS Caremark owes the State of West Virginia $1.4 million in civil penalties after the state’s insurance commissioner found ...
Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and PBMI Innovator Award winner, is calling for a PBM industry focus on making pharmacy experiences more seamless while continuing to ...
Q2 2025 Earnings Call Transcript August 13, 2025 ARS Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $ ...
Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $78.33, with a high estimate of $82.00 and a low estimate of $67.00. Marking an increase of 2 ...
As drug companies increasingly adopt the DTC sales model, patients will gain the ability to buy the medicines they need at ...
3d
24/7 Wall St. on MSN3 Strong Buy High-Yield Dividend Stocks With Over 40% Upside Potential
Three familiar dividend stocks are ideal choices for growth and income investors seeking reliable passive income with growth ...
A recent docuseries exposing alleged abuses by Pharmacy Benefit Managers (PBMs) has been abruptly removed from Amazon Prime ...
People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...
StockStory.org on MSN2d
CVS Q2 Deep Dive: Pharmacy Strength and Aetna Recovery Drive Guidance Boost
Diversified healthcare company CVS Health (NYSE:CVS) in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non ...
Recent legislation in Alabama was designed to rein in the unchecked power of pharmacy benefit managers (PBMs), but patients and independent pharmacies across the state are still paying the price ...
The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results